AbbVie Inc. (alternative manufacturer responsible for production of medicinal product, primary and secondary packaging; alternative manufacturer responsible for testing)

Ukraine

All drugs from this manufacturer

KALETRA

The drug is intended for the treatment of HIV infection in adults and children (from 14 days of age) in combination with other antiretroviral agents.

Dosage form: solution, oral

Active substance	Dosage
lopinavir	80 mg/ml
ritonavir	20 mg/ml